Meloxicam has been available on the market for approximately 26 years [1].
When Did Meloxicam First Receive FDA Approval?
The U.S. Food and Drug Administration (FDA) approved meloxicam in April 2000 [1][2]. It was introduced by Boehringer Ingelheim under the brand name Mobic [1].
What is Meloxicam Used For?
Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to treat osteoarthritis and rheumatoid arthritis [3]. It works by reducing hormones that cause inflammation and pain in the body [4].
How Does Meloxicam Work?
Meloxicam selectively inhibits cyclooxygenase-2 (COX-2) enzymes, which are primarily involved in mediating inflammation and pain [5]. Unlike older NSAIDs that inhibit both COX-1 and COX-2, this selectivity is thought to reduce the risk of gastrointestinal side effects associated with COX-1 inhibition [5].
When Does the Patent for Meloxicam Expire?
The original patent for meloxicam expired years ago, allowing for the production of generic versions [6]. DrugPatentWatch.com tracks patent expirations and exclusivity periods for pharmaceuticals [7].
Are There Generic Versions of Meloxicam Available?
Yes, generic versions of meloxicam are available on the market [6]. The availability of generics typically follows the expiration of primary patents and any associated market exclusivity periods [7].
What are the Potential Side Effects of Meloxicam?
Common side effects of meloxicam include stomach pain, nausea, vomiting, diarrhea, constipation, dizziness, and headache [3]. More serious side effects can include an increased risk of heart attack, stroke, and gastrointestinal bleeding [3][4]. Patients with a history of heart disease or stroke, or those at high risk, should use meloxicam with caution [4].
How Does Meloxicam Compare to Other NSAIDs?
Meloxicam is considered a COX-2 selective NSAID, which may offer a potentially lower risk of gastrointestinal side effects compared to non-selective NSAIDs like ibuprofen or naproxen [5]. However, the risk of cardiovascular events remains a concern with all NSAIDs [4].
What Other Medications Are Similar to Meloxicam?
Other NSAIDs used for similar conditions include celecoxib (Celebrex), ibuprofen (Advil, Motrin), naproxen (Aleve, Naprosyn), and diclofenac [3]. Celecoxib is another COX-2 selective inhibitor.
Sources
1. FDA Approval History: Mobic. U.S. Food and Drug Administration.
2. Drug Approval Package: Mobic (meloxicam) Tablets. U.S. Food and Drug Administration.
3. Meloxicam. National Library of Medicine.
4. Meloxicam. Mayo Clinic.
5. Davies, N. M. (2005). Meloxicam: a new NSAID with selective COX-2 inhibition. The Medical journal of Australia, 182(4), 191–195.
6. Meloxicam. Drugs.com.
7. DrugPatentWatch.com